Table of Contents
Does Medicare Cover Wegovy? The Quick Answer
Key Takeaways
- Two doors: the Bridge prices Wegovy at a flat $50 a month for weight loss through December 31, 2027; Part D plans can separately cover it for heart-disease risk.
- Neither is automatic: the Bridge has four eligibility rules and its own prior authorization; the heart-disease path depends on your plan’s formulary.
- Different drug, different answer: asking about the diabetes-label twin? Start with Ozempic for weight loss — a much shorter story.
Path A: Wegovy for $50 Through the Medicare GLP-1 Bridge
The Medicare GLP-1 Bridge is a temporary CMS demonstration that went live on July 1, 2026 and runs through December 31, 2027. It covers Wegovy for weight loss — injection or tablet — at a flat $50 per one-month supply, regardless of dose or income.
Who qualifies: all four rules
Medicare’s official fact sheet (CMS publication 12234) sets four conditions — you need every one:
- You have Part D drug coverage — a standalone drug plan or a Medicare Advantage plan with drug coverage.
- You can’t already get a GLP-1 through that plan. If it covers one for you for any reason, the Bridge is locked.
- You don’t have type 2 diabetes, moderate-to-severe sleep apnea, or the liver condition MASH. Those conditions go through regular plan coverage instead.
- You’re 18 or older and fit a BMI tier: 35 or higher on its own; 30 or higher with certain heart failure, hard-to-control high blood pressure, or chronic kidney disease stage 3a and up; or 27 or higher with prediabetes or a prior heart attack, stroke, or blocked arteries in the legs or arms.
Three sketches. Say you’re 66 with a BMI of 36 and none of the excluded conditions — rule four clears on BMI alone. Say your BMI is 31 and two medications still can’t settle your blood pressure — that’s the 30-plus tier. Say your BMI is 28 with a stent after a heart attack — the 27-plus tier was written for you.
How the $50 actually happens
There’s no enrollment and nothing to sign up for — the process runs through your doctor:
- Your doctor decides Wegovy for weight loss is appropriate and sends the prescription to the pharmacy.
- The pharmacy needs your Medicare ID — the red-white-and-blue card number — not just your plan card.
- Your doctor files a prior authorization with Medicare’s central processor — not with your Part D plan.
- Medicare mails you a confirmation letter once it’s approved.
- You pick up the prescription and pay $50.
Refills of the same drug don’t need a new prior authorization, even if your dose changes; switching to a different Bridge drug does. If something snags, call 1-800-MEDICARE; the eligibility screener lives at Medicare.gov/glp1bridge.
Path B: Wegovy Part D Coverage for Heart Disease
On March 8, 2024, the FDA approved Wegovy to reduce the risk of cardiovascular death, heart attack, and stroke in adults with established heart disease plus obesity or overweight. CMS soon told Part D plans they may cover Wegovy for that heart indication — because treating heart risk isn’t “weight loss,” which the law still excludes.
Who fits: adults with documented cardiovascular disease — a prior heart attack, a stroke, diagnosed artery disease — plus a qualifying weight. Coverage is plan-by-plan: some formularies list Wegovy for this use, and most that do require prior authorization before the first fill.
What the prior authorization looks like
Your prescriber files it; you don’t submit anything yourself. They attest to your heart-disease diagnosis, your BMI, and that the prescription is for the FDA-approved heart indication rather than weight loss alone. Plans generally must answer a standard request within about 72 hours — 24 when your doctor flags it as urgent.
If the plan says no, ask for a redetermination — a formal second look, usually decided within about seven days. A second no goes to an independent reviewer outside the plan. Say you had a heart attack in 2023 and your BMI is 29 — your cardiologist’s notes do most of the work here.
Which Medicare Wegovy Coverage Path Fits You?
Does Medicare cover Wegovy on both paths at once? No, the paths never overlap — the lockout sees to that:
| Your situation | Your path |
|---|---|
| Type 2 diabetes | Neither — diabetes excludes you from the Bridge; your plan covers diabetes GLP-1s instead. |
| Established heart disease and your plan already covers Wegovy | Path B. Already-plan-covered locks the Bridge; use plan coverage for the heart indication. |
| Fit a BMI tier, none of the three excluded conditions, no GLP-1 available through your plan | Path A — the flat $50 Bridge copay. |
| None of the above | Neither today — see the cash options below. |
What Does Wegovy Cost With Medicare?
So does Medicare cover Wegovy affordably? The same $50 lives entirely outside Part D — and that cuts both ways.
| Cost question | Bridge answer |
|---|---|
| Counts toward the deductible? | No — your plan deductible (up to $615 in 2026) isn’t touched. |
| Counts toward the $2,100 cap? | No — Bridge copays never reach your true out-of-pocket total. |
| Extra Help / LIS? | Doesn’t apply — the $50 stands even with the low-income subsidy. |
| Payment Plan? | Bridge fills can’t be spread through the Medicare Prescription Payment Plan. |
| Coupons? | Manufacturer savings cards are excluded. |
Across the whole demonstration, eighteen $50 fills come to $900 — none counting toward the cap. Path B works the opposite way: deductible and coinsurance, everything counts, and your yearly Wegovy spending stops at the $2,100 cap like any other covered drug. No universal monthly figure exists — it depends on your plan’s tier and the calendar.
If neither door opens, the cash fallback as of July 2026 is NovoCare — also surfaced through TrumpRx — at roughly $149 to $349 a month by dose.
Other GLP-1 Bridge Drugs: Zepbound and Foundayo
Does Medicare cover Wegovy’s alternatives too? Wegovy shares the Bridge with exactly two others. Foundayo (orforglipron), Eli Lilly’s once-daily GLP-1 pill approved April 1, 2026, carries the same $50 copay with no needles. Zepbound (tirzepatide) is covered only as the KwikPen — single-dose pens and vials are excluded. Ozempic, Mounjaro, and Rybelsus aren’t Bridge drugs; plans cover them for their own approved uses.
What Happens to Wegovy Coverage After 2027?
So does Medicare cover Wegovy after 2027? The Bridge is scheduled to end on December 31, 2027, and CMS has not defined what comes after — the law excluding weight-loss drugs from Part D still sits underneath the demonstration. Plan around that date rather than through it. The durable piece is Path B: heart-disease coverage comes from the FDA label and your plan, so it doesn’t expire with the Bridge.
Wegovy Medicare Coverage FAQs
Quick answers to does Medicare cover Wegovy:
Quick answers to the questions readers send most.
1. Does Medicare cover Wegovy, and how much does it cost?
Under the Bridge, the price is a flat $50 for each one-month fill, whatever the dose. Through the heart-disease path, the answer to “does Medicare cover Wegovy” depends on your plan: you pay its deductible and coinsurance until you reach the $2,100 yearly cap. Cash-pay runs roughly $149 to $349 monthly as of mid-2026.
2. Do I qualify for the $50 Wegovy copay?
Four rules decide it: Part D drug coverage, no GLP-1 already available through your plan, none of the three excluded conditions, and a qualifying BMI tier. So does Medicare cover Wegovy at $50 in your case? Check the official screener at Medicare.gov/glp1bridge or call 1-800-MEDICARE before you compare any local pharmacy prices.
3. Does Medicare cover Wegovy tablets the same as the injection?
Both forms follow the same Bridge rules — the drug list names Wegovy as an injection or a tablet, and the copay stays $50 either way. Does Medicare cover Wegovy pills as readily as the pen, in other words? Under the Bridge it does, and same-drug refills skip a new prior authorization even after dose changes.
4. What if my plan denies Wegovy for heart disease?
Ask your prescriber to request a redetermination — the plan must take a second look, usually within about seven days. If it still says no, the case goes to an independent reviewer outside the plan. Meanwhile, the answer to “does Medicare cover Wegovy” could shift to the Bridge, if you also meet its four weight-loss rules.
5. Does the $50 Bridge copay count toward my Part D cap?
The Bridge runs outside Part D entirely, so those flat $50 payments never touch your plan deductible or the $2,100 annual out-of-pocket cap. When people research “does Medicare cover Wegovy,” this is the detail missed most often — Extra Help won’t lower the copay, and the Medicare Prescription Payment Plan can’t spread it out.
6. Can I use a Wegovy savings card with Medicare?
Manufacturer coupons and savings cards are excluded from the Bridge, so the $50 copay is simply the price — no stacking allowed. Plenty of readers land on the question “does Medicare cover Wegovy” after long months of cash coupons, and the switch feels odd, but the program’s rules exclude manufacturer discounts on every Bridge fill.
7. Does Medicare cover Wegovy after the Bridge ends in 2027?
The demonstration is scheduled to end on December 31, 2027, and no follow-on pathway has been defined — the law that excludes weight-loss drugs from Part D is still on the books today. The heart-disease route is different: that coverage comes from the FDA indication and your plan, so it doesn’t expire with the program.
The Bottom Line: Does Medicare Cover Wegovy?
Does Medicare cover Wegovy, then? Twice over — for now. Does Medicare cover Wegovy cheaply? Fit the four Bridge rules and the price is a flat $50 a month through 2027; have established heart disease and your Part D plan may cover it outright. For the Ozempic, Zepbound, and Foundayo sides of the story, the full Medicare weight-loss-drug coverage guide puts the whole program on one page.
Resources
Every source was checked on July 5, 2026.
Leave a Reply